Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-572890
Filing Date
2016-05-02
Accepted
2016-05-02 17:17:33
Documents
66
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d136290d10q.htm 10-Q 633504
2 EX-31.1 d136290dex311.htm EX-31.1 6903
3 EX-31.2 d136290dex312.htm EX-31.2 6895
4 EX-32.1 d136290dex321.htm EX-32.1 3650
5 EX-32.2 d136290dex322.htm EX-32.2 3628
  Complete submission text file 0001193125-16-572890.txt   3587561

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20160331.xml EX-101.INS 526985
7 XBRL TAXONOMY EXTENSION SCHEMA mack-20160331.xsd EX-101.SCH 49014
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20160331_cal.xml EX-101.CAL 64908
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20160331_def.xml EX-101.DEF 158539
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20160331_lab.xml EX-101.LAB 386980
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20160331_pre.xml EX-101.PRE 274487
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 161612678
SIC: 2834 Pharmaceutical Preparations